^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

afamitresgene autoleucel (ADP-A2M4)

i
Other names: ADP-A2M4, SPEAR T-cell therapy targeting the MAGE-A4, Autologous genetically modified MAGE-A4ᶜ¹º³²T cells, MAGE-A4 TCR, afami-cel
Company:
Adaptimmune
Drug class:
TCR modulator, MAGE-A4 inhibitor
Related drugs: